Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
IOVA
Iovance Biotherapeutics
$1.75
Chart
3.33
5.57
7.17
10.01
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
IOVA
Iovance Biotherapeutics
$1.75
Chart
3.33
5.57
7.17
10.01
IOVA Latest Headlines
Iovance Biotherapeutics Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation. Law Offices of Howard G. Smith announces an investigation on behalf of Iovance Biotherapeutics Inc. (Iovance or the Company) (NASDAQ: ) investors concerning the Company'.s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IOVANCE BIOTHERAPEUTICS INC. (IOVA) CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENT
Today
JMP Securities Downgrades Iovance Biotherapeutics (LSE:0JDK). Fintel reports that on May 9 2025 JMP Securities downgraded their outlook for Iovance Biotherapeutics (LSE:0JDK) from Market Outperform to Market Perform.
Today
Securities Fraud Investigation Into Iovance Biotherapeutics Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz. announces an investigation of Iovance Biotherapeutics Inc. (Iovance or the Company) (NASDAQ: ) on behalf of investors concerning the Company'.s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON IOVANCE BIOTHERAPEUTICS INC. (IOVA) CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER
Fri May 9, 2025
Iovance stock tumbles on Q1 revenue miss and guidance cut.
Fri May 9, 2025
Iovance Biotherapeutics Stock Sinks 46%. Heres Why the Biotech Is Tumbling..
Fri May 9, 2025
Iovance falls after guidance cut revenue miss.
Fri May 9, 2025
Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts. Analysts'. ratings for Iovance Biotherapeutics (NASDAQ:) over the last quarter vary from ish to bearish as provided by 9 analysts.The table below provides a concise overview of recent ratings by analysts offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.6210010000110000000041100Providing deeper insights analysts have establish
Fri May 9, 2025
No Excuses Iovance Biotherapeutics Amtagvi Launch Has Underperformed.
Fri May 9, 2025
Iovance Biotherapeutics GAAP EPS of -$0.36 misses by $0.12 revenue of $49.32M.
Thu May 8, 2025
Commit To Buy Iovance Biotherapeutics At $2.50 Earn 35.1% Annualized Using Options. Investors eyeing a purchase of Iovance Biotherapeutics Inc (Symbol: IOVA) shares but cautious about paying the going market price of $3.27/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in par
Mon Apr 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IOVA Stock trends
IOVA Stock performance
IOVA Stock analysis
IOVA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Iovance Biotherapeutics (IOVA) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
